NCT06128928 Connecting Friends and Health Workers to Boost COVID-19 Vaccination in Latino Communities
| NCT ID | NCT06128928 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Johns Hopkins University |
| Condition | COVID-19 |
| Study Type | INTERVENTIONAL |
| Enrollment | 900 participants |
| Start Date | 2023-07-08 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 900 participants in total. It began in 2023-07-08 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to find out which approach works better in getting more of the friends and connections of Latino adults get vaccinated against COVID-19. The main questions this study aims to answer are: 1. Can teaching people to use motivational interviewing help more friends and connections of Latino adults get the COVID-19 vaccine compared to just giving information about the vaccine? 2. What are the things that make it easier or harder for Latinos and networks to get the COVID-19 vaccine? 3. How does this intervention work in practice so that it can be made available to more people in the future The researchers will compare the vaccine rates of the friends and connections of Latinos who have been trained in motivational interviewing with those who have only been given information about the COVID-19 vaccine. This will help figure out which method works best to encourage more people to get vaccinated.
Eligibility Criteria
Inclusion Criteria: Eligibility criteria for index participants (eligibility for index participants is intended to select participants who are less vaccine hesitant): * Age 18 years or older, and * Self-identifies as Hispanic/Latino, and * Living in Maryland, and * Has received at least one COVID-19 vaccine/booster in the last 12 months. Eligibility criteria for primary and secondary network members (peers): Eligibility for peers is intended to select for participants who are more vaccine hesitant (e.g. unvaccinated, or have not received at least one COVID-19 vaccine/booster in the last 12 months) * 18 years old or older, and * Self-identifies as Hispanic/Latino, and * Living in Maryland, and * Provide a study coupon to verify that they were referred by an index or a primary network member, and * Has not received at least one COVID-19 vaccine/booster in the last 12 months. Exclusion Criteria: * Previously participated in the study * Lacks capacity to consent
Contact & Investigator
Kathleen R Page, MD
PRINCIPAL INVESTIGATOR
Johns Hopkins University
Frequently Asked Questions
Who can join the NCT06128928 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying COVID-19. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06128928 currently recruiting?
Yes, NCT06128928 is actively recruiting participants. Contact the research team at kpage2@jhmi.edu for enrollment information.
Where is the NCT06128928 trial being conducted?
This trial is being conducted at Baltimore, United States.
Who is sponsoring the NCT06128928 clinical trial?
NCT06128928 is sponsored by Johns Hopkins University. The principal investigator is Kathleen R Page, MD at Johns Hopkins University. The trial plans to enroll 900 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.